ArticleBMC cancer2012

PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity.

Khalil Choucair et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.